Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2022 | Prehab vs rehab in patients treated with CAR-T therapy

Aimee Green • 8 Feb 2022
CAR-T Meeting 2022
General CAR-T

Aimee Green, The Christie NHS Fund, Manchester, England, outlines the main differences between the services provided in prehab and rehab. Whilst prehab consists of preventing impairment from treatment, rehab consists of addressing any impairments caused by treatment. Both regimens aim to improve the patient’s quality of life (QoL). In patients treated with chimeric antigen receptor T-cell (CAR-T) therapy, these regimens consist of restorative, supportive and palliative care depending on the patient’s outcome and wishes. This interview took place at the EBMT-EHA 4th European CAR T-cell Meeting which was held virtually in 2022.

More from Aimee Green

1:08
Delivering prehab and rehab services to patients treated with CAR-T therapy
Aimee Green • 8 Feb 2022
1:21
Challenges faced by oncology allied health professionals during the COVID-19 pandemic
Aimee Green • 8 Feb 2022
1:25
The impact of CAR-T therapy on patient care
Aimee Green • 8 Feb 2022

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals